Journal of Commercial Biotechnology

Leading thinking on biotechnology business management

Journal of Commercial Biotechnology

The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Vol 21, No 3 (2015)

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents


Combating a Global Pandemic of Weak, Adulterated, and Fake Drugs PDF
Menghis Bairu
The Globetrotting Regulator PDF
Peter J. Pitts
FDA: Is Off-Label on the Table? PDF
Peter Pitts
A ‘Genetically Engineered’ Label: Way More Expensive Than You Think PDF
Henry I Miller, Graham Brookes


Cannabis-Derived Pharmaceuticals PDF
Clifford S Mintz
Venture Capitalists as gatekeepers for Biotechnological Innovation PDF
Kenneth Fernald, Ruud Hoeben, Eric Claassen

From the Boardroom

BioTime’s bid to end age-related disease: A look at CEO Michael West’s Vision PDF
Ian C. Clift

Legal and Regulatory Updates

EU Legal & Regulatory Update – May 2015 PDF
Henry Elliott

Conference Report

Innovation Landscape, Deal-making Strategies and Success Stories PDF
Vasu Pestonjamasp